Search
Redefining Excellence in Heart Transplantation
Part of UCSF Health’s Advanced Heart Failure Comprehensive Care Center, the Heart Transplant and Mechanical Circulatory Support (MCS) Programs treat complex, high-acuity patients while consistently achieving exceptional survival rates, according to the Scientific Registry of Transplant Recipients (SRTR).Redefining Excellence in Kidney Transplantation
UCSF Health’s highly skilled team of kidney transplant specialists has extensive experience in treating medically complex, high-acuity patients while consistently achieving exceptional survival rates, according to the Scientific Registry of Transplant Recipients (SRTR).Redefining Excellence in Liver Transplantation
UCSF Health’s highly skilled team of liver transplant specialists has extensive experience in treating medically complex, high-acuity patients while consistently achieving exceptional survival rates, according to the Scientific Registry of Transplant Recipients (SRTR).Redefining Excellence in Lung Transplantation
As the recipient of INTERLINK’s 2025 Chairman’s Award for Transplant Excellence, UCSF Health’s Lung Transplant Program was recognized as the top-performing lung transplant program in the nation for the third consecutive year.From the Lab to the Living Room: Decoding Parkinson’s Patients’ Movements in the Real World
For people living with Parkinson’s disease, this gap between laboratory research and real-world behavior has limited efforts to improve gait symptoms outside of the clinic.Improving Diagnosis of Aortic Stenosis with Genetics and AI
Joint UCSF and Broad Institute study investigates genetic basis for development of of Aortic Stenosis.How Personalized, Evidence-Based Care Improves High-Risk Pregnancy Outcomes
High-risk complications occur in 6% to 8% of pregnancies in the U.S. and require specialized treatment to ensure the best possible outcomes for both the pregnant patient and the fetus.Prominent Thoracic Surgeon to Lead New Division of Thoracic Surgery at UCSF
Johannes R. Kratz, MD, has been appointed as the inaugural Chief of UCSF’s Division of Thoracic Surgery, one of the leading, academic robotic thoracic surgery programs in the western United States.Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required.Beyond TAVR: Shaping the Next Era of Aortic Stenosis Management
Sammy Elmariah, MD, chief of Interventional Cardiology at UCSF, discusses the latest advances in treating aortic stenosis (AS).UCSF-led Clinical Trial of Patients with Juvenile Arthritis-associated Uveitis Validates Continued Treatment with Adalimumab
In a study published last January in The Lancet, UCSF researchers sought to assess efficacy and safety of discontinuing treatment in patients with juvenile idiopathic arthritis-associated uveitis by conducting a multicenter, randomized-controlled trial at twenty ophthalmology and rheumatology clinics across the U.S., the United Kingdom, and Australia.Could This Precision Medicine Approach Help Patients Delay Dementia?
Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — may predict who is more likely to develop dementia, according to a new study led by UC San Francisco.New Treatment Framework for Anti-Amyloid Therapies Developed by UCSF-led Alzheimer’s Association Consortium
A breakthrough treatment in the fight against Alzheimer’s disease is a class of therapies called anti-amyloid antibodies (anti-A?). These monoclonal antibodies – proteins made in a laboratory intended to stimulate the immune system – have been shown to slow the progression of the disease by targeting amyloid plaques in the brain that are characteristic of Alzheimer’s.Memory and Cognitive Disorders: The Latest Prevention, Diagnostic and Treatment Strategies
In this webinar, behavioral neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, discusses Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease dementia (PDD) and dementia with Lewy body disease (DLB).UCSF Study Finds a Better Way to Screen for Breast Cancer
A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than automatically giving annual mammograms, can lower the chance of more advanced cancers, while still safely matching people to the amount of screening they need.UCSF Urology Clinicians Present Research Findings at SurgeWest
This year’s program featured innovative research and discussions by experts from the UCSF Department of Urology.How a Tumor Marker for Ovarian Cancer May Help Treat the Deadliest Bladder Cancers
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.‘Every Time I Relapsed, There Would Be a New Course of Therapy’
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.Improving Management and Treatment of Thyroid Cancer
UCSF’s Julie Ann Sosa, MD, co-led an international task force establishing new clinical guidelines for the management of differentiated thyroid cancer.Breast Cancer: The Latest Evidence-Based Screening, Diagnostic and Treatment Options
In this informative webinar, UCSF breast surgeon Shoko Emily Abe, MD, reviews current evidence informing breast cancer screening, diagnosis and treatmentCan a Simple Blood Test Measure Fracture Recovery?
A new UCSF-led study has identified a potential early blood-based indicator of long bone fracture healing, offering a powerful new avenue to track recovery and personalize care.Obesity Options in the Ozempic Era: An Expert’s Insights on BMI, GLP-1s and Surgery
Treating obesity is among the PCP's everyday duties, but when does a patient's body composition put them at risk and which treatments are appropriate?Sneaky Senescent Cells That Resist Cancer Treatment Can Provide Druggable Lung Cancer Target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development.Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free
UCSF providing laboratory-produced islet cell therapy as part of clinical trial for Type 1 diabetes patients.